Volume 2 • Issue 2 • 2022 • Summer 2022

Original Research

The United States Food and Drug Administration’s Innovative Alternative Tools to Evaluate Good Clinical Practice During the COVID-19 Public Health Emergency

Kassa Ayalew, Jenn Sellers, Phillip D. Kronstein, Laurie Muldowney, Emily Gebbia, Jean Mulinde and David Burrow

2023-02-10 Volume 2 • Issue 2 • 2022 • Summer 2022

Consensus Papers

What and how will the Risk Based Approach to Monitoring change? Survey of RBM in medical institutions

Kiyoko Adachi, Mayumi Shirase, Yukie Kimura, Yasutoshi Kuboki and Takayuki Yoshino

2022-12-16 Volume 2 • Issue 2 • 2022 • Summer 2022